Apontis Pharma aus Monheim am Rhein hat sich insbesondere auf die Indikationen Herz-Kreislauf-Erkrankungen, Atemwegserkrankungen sowie Diabetes spezialisiert. Die Wurzeln gehen zurück auf die frühere Schwarz Pharma. Der Börsengang erfolgte im Mai 2021.
COMPANY
INVESTOR TERMSHEET
APPH/D
Apontis Pharma
#BGFL Mood:
Negative
·
#BGFL-Indicator:
Reduce
·
Review date:
31.03.2025
LEI:
894500ETO1J6MR8PDF91
SECTOR:
Gesundheit
SUB-SECTOR:
Pharma
NAME
Apontis Pharma
WKN
A3CMGM
ISIN
DE000A3CMGM5
TICKER
APPH
INDEX
EXCHANGE
Xetra
#BGFL-nes Apontis Pharma: boersengefluester.de (BGFL) regularly writes extensive editorial articles for most of the companies in our database - especially those in the special stocks sector. Here we show you a list of the most recent articles by BGFL on the selected share.
| 24.10.2024 | Apontis Pharma: Übernahmeangebot startet |
| 05.04.2024 | Apontis Pharma: Versprechen eingelöst |
| 18.01.2024 | Apontis Pharma: „Es muss ein Ruck durch die Gemeinde gehen“ |
| 30.11.2022 | Apontis Pharma: „Höheres Tempo als zum IPO geplant“ |
| 19.07.2022 | Apontis Pharma: Mit viel Herz dabei |
Visualisation of financial information has been one of boersengefluester.de's (BGFL) favourite disciplines from the very beginning. For this reason, we also put a lot of effort into maintaining our own database and have developed numerous analysis tools and key figure tables on this basis.
Does news drive share prices or does the chain of effects run the other way round - as is often assumed? Well, at boersengefluester.de we offer you all kinds of ways to follow daily stock market events. Take a look at our apps on the subject of news.
Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
